Wealth Enhancement Advisory Services’s Rhythm Pharmaceuticals RYTM Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$204K	Buy	+1,885	New	+$170K	﹤0.01%	3570

Other funds holding RYTM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

EOJOAM

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

AWM

Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

EWP

Elevation Wealth Partners Santa Rosa, California $334M AUM 26.48% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Wealth Enhancement Advisory Services's RYTM Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in Rhythm Pharmaceuticals (RYTM) in Q2 2026: 1,885 shares worth $204K. The stake represents ﹤0.01% of the portfolio and ranks #3570 among its holdings.

20 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

Wealth Enhancement Advisory Services held 1,885 shares of Rhythm Pharmaceuticals worth $204K as of Q2 2026.
Rhythm Pharmaceuticals was a new Wealth Enhancement Advisory Services position in Q2 2026.
Rhythm Pharmaceuticals made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3570 holding.
20 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.